COLLECT SAMPLE
Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.
Harnessing the Power of Mass Spectrometry & Machine Learning to Create Disruptive
ONE Breath at a Time
INSPECTIR SYSTEMS INC
FDA EUA GRANTED 4/1/2022 — EUA220006
READ MORE ABOUT US
The United States is in the midst of a deadly fentanyl epidemic. It is storming our borders and arriving at our ports in overwhelming numbers. Current interdiction methods are costly and dangerous. InspectIR Systems introduces a solution to reduce exposure risks to first responders and canine search assets. This is FIDO.
READ MORE ABOUT FIDOInspectIR's PNY-1000 system is a respiratory test that provides lab-caliber analytics in the field with over 90% sensitivity, delivering results in minutes instead of days.
The system requires no storage of biological material, reducing waste and cross-infection risks.
The COVID-19 pandemic created an unknown situation, and InspectIR Systems responded by initiating research to help, yielding outstanding results.
READ MORE ABOUT US
Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.
Chemistry in the subject's breath is captured on the patented Inspector systems device.
Patent issued measurement process runs, allowing identification & qualification of COVID 19 markers & spectrometry.
InspectIR systems device analyzes and displays results utilizing proprietary software.
InspectIR is the only testing methodology that does not create cross-reactivity, which leads to pre-analytical error, based on adding a solvent.
O que a imprensa diz sobre a InspectIR
Inspect IR is in rapid growth mode… interested in learning more? Complete the form below & a member of our team will be in touch shortly.